Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of HER2 Receptors in Breast Carcinoma by Positron Emission Tomography (PET) Using 89 Zr-Trastuzumab

NCT02065609 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT02065609
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02065609 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of HER2 Receptors in Breast Carcinoma by Positron Emission Tomography (PET) Using 89 Zr-Trastuzumab
Lead sponsor
Washington University School of Medicine
Phase
Phase 1
Overall status
Completed
Start date
February 28, 2014
Completion date
February 13, 2018
Enrollment
52 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer